冠状动脉旁路移植术对慢性完全闭塞的生理影响:基于冠状动脉血流储备的功能评估
本研究回顾性分析1149例接受孤立CABG的患者,比较LAD-CTO组(n=164)与非CTO组(n=985),其中685例测量术后CFR。结果显示CTO组CFR低于非CTO组(2.76±0.90 vs 3.04±0.88,p=0.0012),但所有CTO亚组平均CFR均>2.0,且与Rentrop侧支分级无关。结论认为CABG可为LAD-CTO实现可靠的生理改善和良好结局。
要点
- CABG后LAD-CTO患者平均CFR>2.0,提示生理性改善可靠。
- CTO组CFR低于非CTO组,但差异幅度有限。
- CFR改善不依赖于术前Rentrop侧支分级。
核心结论
- CABG对LAD-CTO血运重建可实现CFR>2.0的可靠生理改善和良好结局,且独立于术前Rentrop侧支分级。
研究设计与样本
- 回顾性分析1149例接受孤立CABG的患者,比较LAD-CTO组(n=164)与非CTO组(n=985),其中685例测量术后CFR。
主要发现
- 全队列中两组早期死亡率(3.7% vs 1.7%,p=0.1018)和LAD桥血管通畅率(97.8% vs 98.6%,p=0.4595)相当。
- CFR队列中CTO组CFR低于非CTO组(2.76±0.90 vs 3.04±0.88,p=0.0012)。
- CTO各侧支亚组平均CFR均>2.0(差:2.66±0.7;中:2.76±0.94;好:2.78±1.00;p=0.763)。
临床怎么用
- 对于LAD-CTO患者,CABG可带来可靠的CFR改善,术前侧支分级不影响生理获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This study evaluated the physiological impact of CABG for left anterior descending (LAD) artery chronic total occlusion (CTO) using postoperative coronary flow reserve (CFR). METHODS: We retrospectively analyzed 1,149 patients undergoing isolated CABG, comparing LAD-CTO (n = 164) and non-CTO (n = 985) groups. Postoperative CFR was measured in 685 patients. The CTO group was stratified by preoperative Rentrop collateral classification. RESULTS: In the entire cohort (n = 1,149), early mortality (3.7% vs. 1.7%, p = 0.1018) and LAD graft patency (97.8% vs. 98.6%, p = 0.4595) were comparable between groups. In the CFR cohort (n = 685), the CTO group showed lower CFR values than the non-CTO group (2.76 ± 0.90 vs. 3.04 ± 0.88, p = 0.0012). However, mean CFR exceeded 2.0 across all CTO subgroups, regardless of collateral status (Poor: 2.66 ± 0.7; Moderate: 2.76 ±0.94; Good: 2.78 ± 1.00; p = 0.763). CONCLUSIONS: CABG achieves reliable physiological improvement (CFR > 2.0) and favorable outcomes for LAD-CTO revascularization, independent of preoperative Rentrop collateral grade.
引用
- Honda K, Kunimoto H, Nakamura R, et al. Physiological impact of coronary artery bypass surgery on chronic total occlusion: a functional evaluation using coronary flow reserve. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42773504. doi:10.1093/icvts/ivag273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。